Danish scientists detect new immune alert signal

June 22, 2012

Researchers from Aarhus University have now located the place in the human body where the earliest virus alert signal triggers the human immune system. They have also discovered a new alarm signal, which is activated at the very first sign of a virus attack.

The groundbreaking finding has just been published in the highly esteemed scientific journal .

"It may turn out that patients suffering from frequent infections actually have problems with activating the mechanism that we have now detected," says Søren Riis Paludan, professor of immunology and virology at Aarhus University, who has completed the study together with Christian Holm, postdoc at Aarhus University.

Cell membrane triggers the alarm

Recent research indicates that our immune system is alerted about a threatening virus infection when genomic material from the virus enters the cell. Researchers from Aarhus University have revealed a process which is triggered already before the foreign genomic material enters the cell, i.e. in the membrane surrounding the cell.

"We have detected a new immune , which helps the cells realize that they may soon get infected with virus," says Søren Riis Paludan.

Without this knowledge, the body cannot start fighting , which then may spread freely and possibly result in e.g. AIDS, hepatitis, influenza and cold sore.

Alarm signals in two directions

"The cellular membranes are in this situation comparable to a borderline territory in looming war – and this is the place to put an outpost," says Christian Holm.

The 'outpost' will send alarm signals in two directions when danger is detected. One signal (outbound) will prepare the body for a possible attack, whereas the other signal (inbound) will make the cell investigate the threat.

"In the present study, we have revealed that this happens – and what this process means. In future studies, we will investigate how this happens", the researchers say.

They add that this new knowledge could also lead to development of more efficient vaccines.

Explore further: Study could help improve gene therapy for heart disease, cancer

More information: "Virus-cell fusion as a trigger of innate immunity dependent on the adaptor STING" Nature Immunology.

Related Stories

Study could help improve gene therapy for heart disease, cancer

October 12, 2011
A Loyola University Chicago Stritch School of Medicine study could lead to improved gene therapies for conditions such as heart disease and cancer as well as more effective vaccines for tuberculosis, malaria and other diseases.

Danger signal limits Hepatitis C infection

September 19, 2011
Despite the fact that hepatitis C virus (HCV) persists chronically in about 80 percent of those infected, some liver cells remain free of the virus even after many years. Now Sung Key Jang of Pohang University of Science ...

Recommended for you

Study explores whole-body immunity

November 21, 2017
Over the next few months, millions of people will receive vaccinations in the hope of staving off the flu—and the fever, pain, and congestion that come with it.

Drug could cut transplant rejection

November 21, 2017
A diabetes drug currently undergoing development could be repurposed to help end transplant rejection, without the side-effects of current immunosuppressive drugs, according to new research by Queen Mary University of London ...

Atopic eczema—one size does not fit all

November 21, 2017
Researchers from the UK and Netherlands have identified five distinct subgroups of eczema, a finding that helps explain how the condition can affect people at different stages of their lives.

Breast milk found to protect against food allergy

November 20, 2017
Eating allergenic foods during pregnancy can protect your child from food allergies, especially if you breastfeed, suggests new research from Boston Children's Hospital. The study, published online today in the Journal of ...

Zika-related nerve damage caused by immune response to the virus

November 20, 2017
The immune system's response to the Zika virus, rather than the virus itself, may be responsible for nerve-related complications of infection, according to a Yale study. This insight could lead to new ways of treating patients ...

How a poorly explored immune cell may impact cancer immunity and immunotherapy

November 17, 2017
The immune cells that are trained to fight off the body's invaders can become defective. It's what allows cancer to develop. So most research has targeted these co-called effector T-cells.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.